A5114029901- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Radiomics and Machine Learning in Medical Imaging
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Fault Detection and Control Systems
- Uterine Myomas and Treatments
- Sensor Technology and Measurement Systems
- Cancer Diagnosis and Treatment
- Neutropenia and Cancer Infections
- Bone health and treatments
- Mineral Processing and Grinding
- Cancer Treatment and Pharmacology
- Cancer Genomics and Diagnostics
- Medical Imaging and Pathology Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer, Stress, Anesthesia, and Immune Response
- Gastrointestinal Tumor Research and Treatment
- Multiple and Secondary Primary Cancers
- Lung Cancer Research Studies
- Esophageal Cancer Research and Treatment
- Bone and Joint Diseases
- Pituitary Gland Disorders and Treatments
Universidade Federal do Rio Grande do Norte
2025
Ministério da Saúde
2025
Hospital de Sant Pau
2019-2022
Complexo Hospitalario Universitario A Coruña
2019
Centro Hospitalar de Vila Nova de Gaia
2019
This study aims to assess the rate of pathological complete response (pCR) in breast cancer patients undergoing neoadjuvant therapy and explore its correlation with clinical, molecular, prognostic factors. We conducted this retrospective observational at Liga Contra o Câncer, a major public oncology reference center Northeast Brazil. included diagnosed who initiated between June 2018 2019. Patients history recurrent or those did not undergo surgery were excluded. The primary outcome was pCR...
12061 Background: Pain and deterioration in quality of life (QoL) are among the most common problematic symptoms reported by patients with late-stage lung cancer. Thus, cannabis sativa extract has been identified as a potencial adjuctive therapy for enhancing QoL managing symptoms, including oncology pain. Objective: The aim is to assess pain management locally advanced or metastatic cancer using extract. Methods: A randomized, prospective, double-blind, placebo-controlled, phase III trial...
Abstract Background Immune-checkpoint inhibitors (ICIs) are a standard-of-care in advanced non-small cell lung cancer (NSCLC). Corticosteroids often used symptomatic patients, but their immunosuppressive effect may reduce the efficacy of ICIs. We report our experience NSCLC and potential impact on-treatment use corticosteroids antibiotics. Methods Medical records 267 patients with receiving ICIs from March 2013 to August 2018 were reviewed. Corticosteroid usage at time initiation or during...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
<b>Introduction:</b> Percutaneous chest biopsy is a valuable and minimally invasive diagnostic procedure. It's considered very safe however, there are inherent risks. <b>Aim:</b> Evaluate CT-guided percutaneous yield safety. <b>Methods:</b> Retrospective observational study of patients submitted to under CT guidance, in one year time period. Core samples were obtained using 18F dual spring system analyzed histologically. <b>Results:</b> The included 217 (average age 66,7 years-old; 67,3%...